Lithium-induced akathisia responds to low-dose mianserin: case report

Int Clin Psychopharmacol. 1995 Nov;10(4):261-3. doi: 10.1097/00004850-199511000-00009.

Abstract

A case of acute akathisia induced by lithium treatment is described. Since lithium administration leads to activation of serotonergic neurotransmission, the 5-HT2A/2C and 5-HT3 antagonist mianserin was added as a possible anti-akathitic agent. Mianserin treatment (15 mg/day at 21.00 h) resulted in amelioration of the lithium-induced akathisia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Akathisia, Drug-Induced / drug therapy*
  • Follow-Up Studies
  • Humans
  • Lithium / adverse effects*
  • Male
  • Mianserin / therapeutic use*
  • Treatment Outcome

Substances

  • Mianserin
  • Lithium